Navigation Links
Actinium Pharmaceuticals, Inc. Receives $3.5m from Exercise of Warrants
Date:6/7/2013

NEW YORK, June 7,­­­­ 2013 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (OTCQB: ATNM) announced today the recent issuance of 2,095,204 of its shares of common stock pursuant to the exercise of A-Warrants originally issued in connection with a private placement that closed in January 2013.  The warrants were exercised at US$ 1.65 per share, resulting in gross proceeds of US$ 3,457,087 for the Company.  As of June 7, 2013 the total number of outstanding common stock is 15,825,394 shares.

"The proceeds from these exercised warrants will be used for the Companies clinical and preclinical programs and for general working capital," said Sergio Traversa, Interim Chief Executive Officer of Actinium Pharmaceuticals.  "This capital will allow us to continue to develop our drug candidates for treatment of the most difficult forms of cancer, including Acute Myeloid Leukemia, where they have made significant advances and already helped a number of patients," added Dragan Cicic, MD, Chief Medical Officer of Actinium Pharmaceuticals.  "The Company intends to advance its programs into late phases of clinical trials and add new programs by the end of 2013."

Shareholders exercised 2,095,204 (67.2%) of the 3,118,988 originally issued A-warrants. 

About Actinium Pharmaceuticals

Actinium Pharmaceuticals, Inc., based in New York, NY, is a biopharmaceutical company that develops innovative alpha particle immunotherapeutics based on its proprietary platform for the therapeutic utilization of alpha particle emitting actinium-225 and bismuth-213 radiopharmaceuticals in association with monoclonal antibodies.

For more information:

Visit our web site www.actiniumpharmaceuticals.com or

Contact:
'/>"/>

SOURCE Actinium Pharmaceuticals Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Actinium Pharmaceuticals Clinical Results to be Presented at 8th International Symposium on Targeted Alpha Therapy Conference
2. Actinium Pharmaceuticals, Inc. Receives Notice of Patent Allowance for a Key Application
3. Cactus Ventures, Inc. Changes Name to Actinium Pharmaceuticals, Inc.
4. Actinium Pharmaceuticals, Inc. To Present at the 15th Annual BIO CEO Investor Conference
5. Actinium Pharmaceuticals to Present at EMIT Targeted Radiotherapy Conference
6. University of Pennsylvania joins Actinium Pharmaceuticals Multicenter Actimab-A Trial
7. Additional Clinical Data from Two Trials on Actinium Pharmaceuticals Iomab-B to be Presented at American Society of Hematology (ASH) Annual Meeting
8. Actinium Pharmaceuticals Sponsors Webinar on Clinical Use of Alpha Immunotherapy
9. Actinium Pharmaceuticals Announces New Round of Financing
10. Gerri Henwood Joins Actinium Pharmaceuticals as Chief Development Officer
11. Actinium Pharmaceuticals Commences Screening for the Second Cohort of Patients in the Companys Ongoing Phase I/II Trial in Acute Myeloid Leukemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... -- Market research firm Kalorama information says that 2014 will ... the medical device industry.  The firm thinks the $360 ... 3% growth this year, which led firms to look ... and entrance by acquisition into new competitive zones.  The ... The Global Market for Medical Devices, 5 th ...
(Date:11/21/2014)... 20, 2014 /CNW Telbec/ - KLOX Technologies Inc. ("KLOX" ... appointments: Todd Martensen has ... created role of Chief Commercial Officer, to oversee KLOX,s ... photoconverter gel for the treatment of chronic and other ... recently approved in Europe . Mr. ...
(Date:11/21/2014)... , Nov. 20, 2014 Depomed, Inc. (NASDAQ: ... the Piper Jaffray 26 th Annual Healthcare Conference in ... the Piper Jaffray conference is scheduled for 8:00 am EST (5:00 ... webcast, and the webcast can be accessed via the Investor Relations ... of the webcast will be archived for 30 days on the ...
Breaking Medicine Technology:Kalorama: 2014 The "Year of The Buy" in Medical Device Industry 2KLOX Technologies announces executive appointments 2KLOX Technologies announces executive appointments 3KLOX Technologies announces executive appointments 4Depomed To Present At Piper Jaffray 26th Annual Healthcare Conference 2
... PDL BioPharma, Inc. (PDL) (NASDAQ: ... third quarter financial results for the period ended September 30, ... PDL,s management will host a conference call and webcast that ... results. (Logo: http://photos.prnewswire.com/prnh/20110822/SF55808LOGO) Conference ...
... Abbott,s PLEX-ID system provides reliable and rapid results ... as a first line analytical tool for biodefense, biosecurity ... the 13th Medical Biodefense Conference in Munich.  The meeting ... covering the latest developments in the diagnosis, therapy and ...
Cached Medicine Technology:PDL BioPharma to Announce Third Quarter 2011 Financial Results on November 9, 2011 2Experts Report that Abbott's New PLEX-ID Assay Offers Important Testing Capabilities for Biothreat Defense 2
(Date:11/21/2014)... November 21, 2014 Recently, VogueQueen ... launched a wedding dress promotion for the coming holiday ... a special offer when checking out. , The beach ... 2014. The customers like the designs for the premium ... would not only be good for the environment, they ...
(Date:11/21/2014)... Lauderdale, Florida (PRWEB) November 21, 2014 ... for chronic headaches and other jaw-related symptoms, ... patients seeking relief from chronic head pain, neck pain, ... , “This year we have seen a 52% ... treated. Our network of over 300 doctors and their ...
(Date:11/21/2014)... Recently, TideStore.com, a leading online store ... its special offer TideStore Thanksgiving Sales . According ... are now provided with big discounts. The special offer ... enjoy an extra 10% discount with this coupon code: ... and have opportunities to win free gifts. TideStore.com has ...
(Date:11/21/2014)... Delhi, India (PRWEB) November 21, 2014 ... repair and manage the online reputation of lawyers, and ... , RankingBySEO has announced the service for lawyers since ... of their online reputation in big numbers. So far, ... many lawyers and law firms in different parts of ...
(Date:11/21/2014)... M3 Global Research , a market ... today announced two important leadership changes to help accelerate the ... of Market Research, Americas and the promotion of Anton Richter ... Ms. DasGupta joined M3 in 2011 and has held the ... Sales. Roni has over 17 years of experience in ...
Breaking Medicine News(10 mins):Health News:Beach Wedding Dresses on Sale for the Coming Holiday Season at VogueQueen.com 2Health News:National Rise In Patients Seeking Headache Relief 2Health News:Thanksgiving Sales from TideStore.com 2Health News:RankingBySEO Announces Lawyer Reputation Management Service 2Health News:M3 Global Research Announces Leadership Team Promotions in US and EU 2
... with history of repeat surgeries likely to face infection, ... -- Patients with implantable cardioverter defibrillators (ICDs) who,ve had ... suffering complications after ICD replacement, according to a study ... Canada. , Dr. Andrew Krahn, of the London ...
... Mary Beth Bolton, MD, FACP, a Detroit internal medicine specialist, ... Michigan State Medical Society (MSMS). , , ... Officer with Health Alliance Plan (HAP) since 2000, was recognized ... to improving primary patient care through increasing access, promoting wellness ...
... The Susan G. Komen for the Cure(R),Advocacy Alliance today applauded ... Secretary of Health and Human Services and director of the,White ... that,Daschle has long been a leader on health care issues, ... to breast cancer. , ...
... hemodynamic monitor (IHM) may help to guide medical treatment ... with diastolic heart failure (DHF), reports a study in ... http://www.onlinejcf.com/ ), published by Elsevier. , Led by Michael ... Charleston, the researchers analyzed data on DHF patients enrolled ...
... annually and aim to strengthen science in selected member ... The EMBC Member States hosting the grantees finance the ... include Croatia, the Czech Republic, Estonia, Hungary, Poland, Portugal ... for three to five years to help them establish ...
... by Plans in Multiple States, Lockheed Martin Presents Example ... Local-Level Opportunities , , ... the leading provider of managed care market intelligence, finds ... Martin works with carriers across the country to provide ...
Cached Medicine News:Health News:Multiple ICD Replacements Can Predict Complications 2Health News:Mary Beth Bolton, MD, Named 'Woman Physician of the Year' by Michigan State Medical Society 2Health News:Susan G. Komen for the Cure(R) Advocacy Alliance Applauds Selection of Senator Tom Daschle for HHS Secretary, White House Health Reform Czar 2Health News:Implantable monitor may help in managing diastolic heart failure 2Health News:Employer Vantage From HealthLeaders-InterStudy Provides a Snapshot of Both Self- and Fully-Insured Health Benefits to Help Pharmaceutical and Diagnostic Manufacturers Identify Business Opportunities 2Health News:Employer Vantage From HealthLeaders-InterStudy Provides a Snapshot of Both Self- and Fully-Insured Health Benefits to Help Pharmaceutical and Diagnostic Manufacturers Identify Business Opportunities 3
A fully automated, benchtop instrument designed for high-volume urine testing, using Siemens' proven technology in dry-pad urine chemistry analysis....
... to near-patient urinalysis. The Chemstrip ... affordable, reliable alternative to visual ... fundamental, easy-to-use features, the Chemstrip ... office lab, clinic, and hospital ...
... In today's busy physician's office ... can contribute to timing errors ... urinalysis strips are read visually. ... urinalysis is performed with an ...
... The Clinitek 50 analyzer is an ... smaller laboratories the reliability and consistency ... better, more efficient way to obtain ... settings demand an economy of motion ...
Medicine Products: